We now further expand our original hypothesis to include VEGFR-2 signaling as a significant contributor to P2YR-induced angiogenesis, which cancer cells can exploit to pathological advantage by secretion of NDPK (Figure 3). The gene discussed is KDR; the disease is cancer.